Cancer isn’t just one disease, but many — each with its own challenges, characteristics, risks and treatments. As we have ...
In this discussion with Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center, she illustrates how Vanderbilt works to ...
Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response ...
The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact cancer progression and treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback